Literature DB >> 20192953

Chlamydia trachomatis, a hidden epidemic: effects on female reproduction and options for treatment.

Alison J Carey1, Kenneth W Beagley.   

Abstract

The number of genital tract Chlamydia trachomatis infections is steadily increasing worldwide, with approximately 50-70% of infections asymptomatic. There is currently no uniform screening practice, current antibiotic treatment has failed to prevent the increased incidence, and there is no vaccine available. We examined studies on the epidemiology of C. trachomatis infections, the effects infections have on the female reproductive tract and subsequent reproductive health and what measures are being taken to reduce these problems. Undetected or multiple infections in women can lead to the development of severe reproductive sequelae, including pelvic inflammatory disease and tubal infertility. There are two possible paradigms of chlamydial pathogenesis, the cellular and immunological paradigms. While many vaccine candidates are being extensively tested in animal models, they are still years from clinical trials. With no vaccine available and antibiotic treatment unable to halt the increased incidence, infection rates will continue to increase and cause a significant burden on health care systems.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20192953     DOI: 10.1111/j.1600-0897.2010.00819.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  17 in total

Review 1.  Rho GTPases as pathogen targets: Focus on curable sexually transmitted infections.

Authors:  Cristián A Quintero; Julián Gambarte Tudela; María T Damiani
Journal:  Small GTPases       Date:  2015-05-29

2.  Golgi-associated Rab14, a new regulator for Chlamydia trachomatis infection outcome.

Authors:  Anahí Capmany; Natalia Leiva; María Teresa Damiani
Journal:  Commun Integr Biol       Date:  2011-09-01

3.  Brefeldin A, but not monensin, enables flow cytometric detection of interleukin-4 within peripheral T cells responding to ex vivo stimulation with Chlamydia trachomatis.

Authors:  Rodolfo D Vicetti Miguel; Samantha A Maryak; Thomas L Cherpes
Journal:  J Immunol Methods       Date:  2012-07-29       Impact factor: 2.303

Review 4.  Immunity and vaccines against sexually transmitted Chlamydia trachomatis infection.

Authors:  Sarah E M Howie; Patrick J Horner; Andrew W Horne; Gary Entrican
Journal:  Curr Opin Infect Dis       Date:  2011-02       Impact factor: 4.915

5.  Synthesis of chlamydia lipopolysaccharide haptens through the use of α-specific 3-iodo-Kdo fluoride glycosyl donors.

Authors:  Barbara Pokorny; Paul Kosma
Journal:  Chemistry       Date:  2014-10-29       Impact factor: 5.236

6.  Public health policies and management strategies for genital Chlamydia trachomatis infection.

Authors:  Kelly Shaw; David Coleman; Maree O'Sullivan; Nicola Stephens
Journal:  Risk Manag Healthc Policy       Date:  2011-05-19

7.  Screening for Chlamydia trachomatis in Egyptian women with unexplained infertility, comparing real-time PCR techniques to standard serology tests: case control study.

Authors:  Rana M A Abdella; Hatem I Abdelmoaty; Rasha H Elsherif; Ahmed Mahmoud Sayed; Nadine Alaa Sherif; Hisham M Gouda; Ahmed El Lithy; Maged Almohamady; Mostafa Abdelbar; Ahmed Naguib Hosni; Ahmed Magdy; Youssef Ma
Journal:  BMC Womens Health       Date:  2015-06-02       Impact factor: 2.809

8.  Chlamydia trachomatis load in population-based screening and STI-clinics: implications for screening policy.

Authors:  Jeanne A M C Dirks; Petra F G Wolffs; Nicole H T M Dukers-Muijrers; Antoinette A T P Brink; Arjen G C L Speksnijder; Christian J P A Hoebe
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

Review 9.  Home-based versus clinic-based specimen collection in the management of Chlamydia trachomatis and Neisseria gonorrhoeae infections.

Authors:  Luisa Fajardo-Bernal; Johanna Aponte-Gonzalez; Patrick Vigil; Edith Angel-Müller; Carlos Rincon; Hernando G Gaitán; Nicola Low
Journal:  Cochrane Database Syst Rev       Date:  2015-09-29

10.  Testing for Chlamydia trachomatis: time trends in positivity rates in the canton of Basel-Stadt, Switzerland.

Authors:  C Schmutz; D Burki; R Frei; M Mäusezahl-Feuz; D Mäusezahl
Journal:  Epidemiol Infect       Date:  2012-11-19       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.